Entheon Biomedical Corp. reported earnings results for the third quarter and nine months ended August 31, 2024. For the third quarter, the company reported net loss was CAD 0.064703 million compared to CAD 0.094856 million a year ago.
For the nine months, net loss was CAD 0.234123 million compared to CAD 0.226437 million a year ago. Basic loss per share from continuing operations was CAD 0.03 compared to CAD 0.04 a year ago.